Related Experiment Video

Updated: Oct 13, 2026

A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds
02:49

A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds

Published on: February 23, 2024

Is there a role for growth hormone in the clinical management of burn injuries?

R J Ramirez1, S E Wolf, D N Herndon

  • 1Shriners Hospitals for Children, University of Texas Medical Branch, USA.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|September 16, 2000
PubMed

Insights

Growth hormone (GH) offers significant benefits for pediatric burn patients by reducing tissue breakdown and promoting healing. This anabolic agent can be safely administered, improving recovery and reducing complications in children with severe burns.

Area of Science:

  • Pediatric Burn Management
  • Endocrinology
  • Trauma Recovery

Background:

  • Pediatric burn patients experience severe hypercatabolism, leading to tissue wasting and delayed healing.
  • Growth hormone (GH) is a known anabolic agent with potential therapeutic benefits in critical illness.

Purpose of the Study:

  • To evaluate the advantages and safety of growth hormone (GH) administration in hypercatabolic pediatric burn patients.
  • To assess the impact of GH on protein synthesis, wound healing, and overall morbidity in pediatric burn survivors.

Main Methods:

  • Administration of growth hormone (GH) to pediatric patients with severe burn injuries.
  • Monitoring of anabolic and catabolic markers, wound healing rates, and patient outcomes.
  • Evaluation of potential side-effects associated with GH therapy in this cohort.

Main Results:

  • Growth hormone (GH) demonstrated potent anabolic effects, counteracting trauma-induced catabolism.
  • GH administration led to accelerated wound healing and reduced tissue wasting.
  • Treatment with GH was associated with minimal adverse side-effects in the pediatric burn population.

Conclusions:

  • Growth hormone (GH) is a safe and effective therapeutic agent for hypercatabolic pediatric burn patients.
  • GH improves protein synthesis, accelerates wound healing, and reduces morbidity in pediatric burn care.
  • Ongoing research explores novel delivery methods, extended treatment durations, and combination therapies for GH in burn management.

More Related Videos

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment07:45

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Published on: November 6, 2018

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...